Emkay Global Q1 FY27 PAT more than doubles YoY, no fund deviation
EMKAY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 2.3 pts less than its Stockbroking & Allied peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Emkay Global reported Q1 FY27 standalone revenue of Rs 83.00 crore (up 27% YoY) and PAT of Rs 6.65 crore (up 141% YoY). Consolidated revenue rose 26% to Rs 91.92 crore with PAT up 90% at Rs 9.11 crore. EPS basic at Rs 2.48 standalone and Rs 3.39 consolidated. ICRA reaffirmed BBB+ Positive rating on NCDs. Company filed nil deviation statement for proceeds of preferential warrants, fully utilised for working capital.
Strong profit growth, clean auditor review, and no fund deviation. Positive signal on earnings momentum and disciplined capital use.